4//SEC Filing
Katz Michael David M.D. 4
Accession 0001619964-24-000020
CIK 0001828588other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 1:55 PM ET
Size
9.0 KB
Accession
0001619964-24-000020
Insider Transaction Report
Form 4
Katz Michael David M.D.
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option
2024-04-09−7,057→ 0 totalExercise: $10.00From: 2017-10-01Exp: 2024-10-01→ Common Stock (7,057 underlying) - Exercise/Conversion
Common Stock
2024-04-09$10.00/sh+7,057$70,570→ 154,279 total
Holdings
- 40(indirect: See Footnote 1)
Common Stock
- 96,760(indirect: See Footnote 2)
Common Stock
- 25(indirect: See Footnote 1)
Common Stock
Footnotes (2)
- [F1]As custodian for reporting person's grandchild
- [F2]Held by a trust to which Dr. Katz is a beneficiary
Documents
Issuer
Hanover Bancorp, Inc. /NY
CIK 0001828588
Entity typeother
Related Parties
1- filerCIK 0001919798
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 1:55 PM ET
- Size
- 9.0 KB